Clinical Trial Update: Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of vinorelbine plus gemcitabine for platinum-resistant recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Status: COMPLETED